Skip to content
Sunday 23 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,816.56
+0.64%
DAX
26,136.56
+0.59%
CAC 40
8,484.43
+0.37%
STOXX 50
6,462.22
+0.63%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Thursday 13 January 2022 9:35 am  |  Updated:  Thursday 13 January 2022 9:39 am

Next slide please: Professor Van-Tam leaves England’s deputy chief medical officer role

By: Leah Montebello

Add as a preferred source on Google
(Photo by Yui Mok – WPA Pool/Getty Images)

Professor Sir Jonathan Van-Tam has announced he will be leaving his role as England’s deputy chief medical officer from March.

Announcing his resignation, Sir Jonathan said it had been the ‘greatest privilege of my professional career’ to serve the UK public during the pandemic.

Health Secretary Sajid Javid said it had been “an honour” to work with the scientist and he was “hugely grateful for his advice”.

Sir Jonathan became known for his regular appearances in the government’s coronavirus briefings.

He had been on secondment to the Department of Health from the University of Nottingham for a number of years, according to the BBC.

Sir Jonathan, also known as JVT, said: ‘My time as deputy chief medical officer has been the most challenging of my professional career, especially the Covid response. 

“We all wish Covid had never happened. Notwithstanding, it has been the greatest privilege of my professional career to have served the people of the UK during this time.”

“I want to pay tribute to Professor Chris Whitty, the CMO team, my fellow scientists, public health professionals and clinicians whose support, wisdom and energy has been inspiring.”

“There are countless numbers who work behind the scenes — all of whom have an unrelenting commitment to help and support the British public. It has been an honour to work with them all.”

It is not yet known what position Sir Jonathan will take on.

Read more

Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Politics

Related Topics

  • Coronavirus

Trending Articles

  • Can debt-ridden Morrisons become a Big Four supermarket again?

  • Ratcliffe’s Ineos saves Runcorn plant

  • Mike Ashley’s Frasers offers to pay personal shoppers in Harvey Nichols takeover

  • Burnham predicted to raise taxes for ‘fundamental’ cost of living support

  • Amazon says it buys books in bulk to ‘improve products’

More from Morning Wire

  • Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development

    Business Wire
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • Jonathan Reynolds’ industrial strategy is straight out of the 60s

    Opinion
    Labour's Jonathan Reynolds unveiled the industrial strategy in June.
  • Burnham facing calls to cut employment red tape as job seekers grow for 41 months

    Economics
    Office for National Statistics
  • Where are Andy Burnham’s economic advisers?

    Politics
    Andy Burnham and John Healey at Number 10 North, both wearing suits and ties, with a microphone in the foreground.
  • Top economists shun Burnham over wealth taxes

    Politics
    Andy Burnham speaking at a press conference, expressing confidence despite challenges, highlighting leadership and resilie...
  • Hiscox finance chief: London’s AI adoption is too slow

    Opinion
    Paul Cooper, a man in a navy suit, gestures during a business meeting at a conference table.
  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook